New treatment for malaria
Glaxo Smith Kline and the World Health Organisation(WHO) have recently announced that they have signed an agreement for the development of a new treatment for malaria called LAPDAP.
Related Content
- World malaria report 2021
- Mitigating The Impact Of Covid-19 On Countries Affected By Hiv, Tuberculosis And Malaria
- Enabling Delivery of Essential Health Services during the COVID 19 Outbreak: Guidance note
- World malaria report 2019
- Burden of disease and climate interactions: an illustrative study of Surat City, India
- Demonstrating the cost-effectiveness and sustainability of environmentally sound and locally appropriate alternatives to DDT for malaria vector control in Africa 2009–2017